Therapeutic Applications of Octreotide in Pediatric Patients

被引:20
作者
Al-Hussaini, Abdulrahman [1 ]
Butzner, Decker [2 ]
机构
[1] Dept Pediat, Div Gastroenterol, Riyadh, Saudi Arabia
[2] Univ Calgary, Dept Pediat, Div Gastroenterol, Calgary, AB T2N 1N4, Canada
关键词
Chronic diarrhea; dumping syndrome; gastrointestinal bleeding; octreotide; pancreas; SOMATOSTATIN ANALOG SMS-201-995; RANDOMIZED CONTROLLED-TRIAL; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; LONG-TERM TREATMENT; ACUTE-PANCREATITIS; DUMPING SYNDROME; SMS; 201-995; POSTOPERATIVE CHYLOTHORAX; ESOPHAGEAL-VARICES; LINEAR GROWTH;
D O I
10.4103/1319-3767.93807
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aim: We report our experience with the use of octreotide as primary or adjunctive therapy in children with various gastrointestinal disorders. Patients and Methods: A pharmacy database identified patients who received octreotide for gastrointestinal diseases. Indications for octreotide use, dosing, effectiveness, and adverse events were evaluated by chart review. Results: A total of 21 patients (12 males), aged 1 month to 13 years, were evaluated. Eleven received octreotide for massive gastrointestinal bleeding caused by portal hypertension-induced lesions (n=7), typhlitis (1), Meckel's diverticulum (1), and indefinite source (2). Blood transfusion requirements were reduced from 23 +/- 9 mL/kg (mean +/- SD) to 8 +/- 15 (P<0.01). Four patients with pancreatic pseudocyst and/or ascites received octreotide over 14.0 +/- 5.7 days in 2 patients. In 3 children, pancreatic pseudocyst resolved in 12 +/- 2 days and pancreatic ascites resolved in 7 days in 2. Three patients with chylothorax received octreotide for 14 +/- 7 days with complete resolution in each. Two infants with chronic diarrhea received octreotide over 11 +/- 4.2 months. Stool output decreased from 85 +/- 21 mL/kg/day to 28 +/- 18 mL/kg/day, 3 months after initiation of octreotide. The child with dumping syndrome responded to octreotide in a week. Adverse events developed in 4 patients: Q-T interval prolongation and ventricular fibrillation, hyperglycemia, growth hormone deficiency, and hypertension. Conclusion: Octreotide provides a valuable addition to the therapeutic armamentum of the pediatric gastroenterologist for a wide variety of disorders. Serious adverse events may occur and patients must be closely monitored.
引用
收藏
页码:87 / 94
页数:8
相关论文
共 70 条
[1]   Successful use of somatostatin in a case of neonatal chylothorax [J].
Au, M ;
Weber, TR ;
Fleming, RE .
JOURNAL OF PEDIATRIC SURGERY, 2003, 38 (07) :1106-1107
[2]  
Ballinger AB, 1998, EUR J GASTROEN HEPAT, V10, P699
[3]   OCTREOTIDE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN CONDITIONS ASSOCIATED WITH EXCESSIVE PEPTIDE SECRETION [J].
BATTERSHILL, PE ;
CLISSOLD, SP .
DRUGS, 1989, 38 (05) :658-702
[4]   Etiology and management of pediatric chylothorax [J].
Beghetti, M ;
La Scala, G ;
Belli, D ;
Bugmann, P ;
Kalangos, A ;
Le Coultre, C .
JOURNAL OF PEDIATRICS, 2000, 136 (05) :653-658
[5]   SCLEROTHERAPY WITH OR WITHOUT OCTREOTIDE FOR ACUTE VARICEAL BLEEDING [J].
BESSON, I ;
INGRAND, P ;
PERSON, B ;
BOUTROUX, D ;
HERESBACH, D ;
BERNARD, P ;
HOCHAIN, P ;
LARRICQ, J ;
GOURLAOUEN, A ;
RIBARD, D ;
KARA, NM ;
LEGOUX, JL ;
PILLEGAND, B ;
BECKER, MC ;
DICOSTANZO, J ;
METREAU, JM ;
SILVAIN, C ;
BEAUCHANT, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (09) :555-560
[6]   Octreotide therapy: a new horizon in treatment of iatrogenic chyloperitoneum [J].
Bhatia, C ;
Pratap, U ;
Slavik, Z .
ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 85 (03) :234-235
[7]   OCTREOTIDE IN THE TREATMENT OF ACUTE-PANCREATITIS - RESULTS OF A UNICENTER PROSPECTIVE TRIAL WITH 3 DIFFERENT OCTREOTIDE DOSAGES [J].
BINDER, M ;
UHL, W ;
FRIESS, H ;
MALFERTHEINER, P ;
BUCHLER, MW .
DIGESTION, 1994, 55 :20-23
[8]   Somatostatin in the treatment of a pancreatic pseudocyst in a child [J].
BosmanVermeeren, JM ;
VeeremanWauters, G ;
Broos, P ;
Eggermont, E .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1996, 23 (04) :422-425
[9]   ETIOLOGY AND TREATMENT OF CHYLOUS ASCITES [J].
BROWSE, NL ;
WILSON, NM ;
RUSSO, F ;
ALHASSAN, H ;
ALLEN, DR .
BRITISH JOURNAL OF SURGERY, 1992, 79 (11) :1145-1150
[10]   Somatostatin and octreotide in acute pancreatitis: the never-ending story [J].
Cavallini, G ;
Frulloni, L .
DIGESTIVE AND LIVER DISEASE, 2001, 33 (02) :192-201